KIMFLEXOR, S.L.

CHONDROPHARM

Pharmaceutical products for the treatment of neurological diseases and disorders, central nervous system diseases and disorders, circulatory diseases and disorders, cardiovascular diseases and disorders, muscular and rheumatic diseases and disorders, joint diseases and disorders, bone diseases and disorders, musculoskeletal diseases and disorders, arthritis, osteoporosis, degenerative osteoarthritis, immune system diseases and disorders, ocular diseases and disorders, diseases and disorders affecting vision, autoimmune diseases and disorders, sports-related diseases and disorders, acquired immunodeficiency syndrome, cancer; pharmaceutical products for use in controlling or reducing inflammation in sports medicine, namely, gels, ointments, salves and sprays; anti-coagulants; dietetic sugar and foods adapted for medical use; nutritional supplements for medical use, food supplements for medical use, nutraceuticals for use as a dietary supplement standing alone and as food additives and ingredients;